Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " May 31, 2009":" June 30, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
2 Completed Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: SAV001-H
3 Completed Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
Conditions: HIV Infections;   Smokers
Intervention:
4 Completed CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
Condition: HIV Infections
Intervention: Drug: Maraviroc
5 Completed A Study of Anti-HIV Monoclonal Antibody KD-247
Condition: HIV Infections
Interventions: Drug: KD-247;   Drug: Physiological saline
6 Completed Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
Condition: HIV Infection
Interventions: Biological: DermaVir;   Biological: Placebo;   Drug: HAART
7 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
8 Completed
Has Results
Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
9 Completed Natural History Study of HIV Acquired in Infancy or Childhood
Condition: HIV Infections
Intervention:
10 Suspended Cognitive Rehabilitation in Ugandan Children With HIV
Condition: HIV Infections
Interventions: Behavioral: Computerized cognitive rehabilitation therapy (CCRT);   Behavioral: control group
11 Completed
Has Results
Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People
Condition: HIV Infection
Intervention:
12 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
13 Completed An Expanded Safety Study of Dapivirine Gel 4759 in Africa
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: dapivirine;   Drug: placebo
14 Completed Efficacy and Safety of Varenicline Among HIV-infected Patients
Conditions: HIV Infections;   Tobacco Dependence
Interventions: Drug: Varenicline;   Drug: Placebo
15 Completed HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
16 Completed Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
17 Completed Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients
Conditions: HIV;   Atherosclerosis;   HIV Infections
Interventions: Other: consumption 1. EVOO; 2. ROO;   Other: consumption 1. ROO; 2. EVOO
18 Completed An Expanded Safety Study of Dapivirine Gel 4789 in Africa
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Healthy
Interventions: Drug: dapivirine;   Drug: placebo
19 Completed
Has Results
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
Condition: HIV
Interventions: Drug: atazanavir/raltegravir;   Drug: atazanavir/tenofovir/emtricitabine
20 Completed
Has Results
A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.